Table 1.

Palliative radiotherapy for hepatocellular carcinoma metastatic sites

Ref.	Metastatic lesion treated	Patient (n)	Total dose, fraction size	Response	Median survival
Yamashita et al[122] (Retro)	LNs	28	46-60 Gy, 2Gy	PR: 64%; CR: 18%	13 mo
Zeng et al[29] (Retro)	LNs	62	40-60 Gy, 2 Gy	PR: 37.1%; CR: 59.7%	9.4 mo
He et al[121] (Retro)	Bone	30	8-60 (median 40) Gy	96.7% pain relief	8.6 mo
Seong et al[26] (Retro)	Bone	51	12.5-50 (median 30) Gy	73% pain relief	5 mo
Kaizu et al[123] (Retro)	Bone	57	20-65 (mean 43) Gy	83.8% pain relief	6 mo

PR: Partial response; CR: Complete response; Retro: Retrospective study; LNs: Lymphnodes.